775 abstracts found.



Evaluating the utility of hepatoma arterial-embolization prognostic (HAP) score in clinical practice to provide prognosis of hepatocellular carcinoma (HCC) irrespective of treatment modalities

Year:

Session type:

Theme:

Nor Farzana Abdul Aziz1,Andrew Yeoman2,Marek Czajkowski2
1Cardiff University School of Medicine,2Royal Gwent Hospital, Newport

Three-Year Efficacy and Safety Update From the Phase III CheckMate 025 Study of Nivolumab Versus Everolimus in Patients With Advanced Renal Cell Carcinoma (aRCC)

Year:

Session type:

Theme:

Padmanee Sharma1,Scott S Tykodi2,Bernard Escudier3,Michael Carducci4,Stephane Oudard5,Hans J. Hammers4,Saby George6,Daniel Castellano7,Ajjai S. Alva8,Martin E Richardet9,Christine Chevreau10,Elizabeth R. Plimack11,Sandhya Srinivas12,Giuseppe Procopio13,Jeffrey A. Sosman14,David F. McDermott15,Toni K. Choueiri16,Elmer Berghorn17,Lingfeng Yang17,Robert J. Motzer18,John Wagstaff19
1MD Anderson Cancer Center,2University of Washington and Fred Hutchinson Cancer Research Center,3Gustave Roussy,4Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,5Hôpital Européen Georges Pompidou,6Roswell Park Cancer Institute,7Hospital Universitario,8University of Michigan,9Instituto Oncologico de Cordoba,10IUCT-O Institut Claudius Regaud,11Fox Chase Cancer Center,12Stanford Cancer Institute,13Fondazione Istituto Nazionale,14Vanderbilt University Medical Center,15Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center,16Dana-Farber Cancer Institute/Brigham and Women’s Hospital,17Bristol-Myers Squibb,18Memorial Sloan Kettering Cancer Center,19Swansea University

Primary endocrine therapy in elderly women with hormone sensitive breast cancer: disease response and clinical benefit outcomes

Year:

Session type:

Theme:

Walid Sasi1,Petros Christopoulos1,Mihai Mancas1,Claire Murphy1
1Airedale General Hospital

Allowing GPs to Book 2-week Wait CRC Investigations Directly-Will we Open the Floodgates?

Year:

Session type:

Theme:

Deji Odofin1,Anne Pullyblank2,Eric Loveday2,Anne Lyons2
1Walsall Healthcare NHS Trust,2North Bristol NHS Trust

Safety of Nivolumab in Patients With Clear Cell (CC) or Non-Clear Cell (NCC) Renal Cell Carcinoma (RCC): Results From the Phase IIIb/IV CheckMate 374 Study

Year:

Session type:

Theme:

Joshua McFarlane1,Mark Olsen2,Ana Molina3,Todd M. Bauer4,Scott Tykodi5,Bradley Somer6,Mayer Fishman7,James Reeves8,Vijay Gunuganti9,Ray Page10,Sunil Babu11,Saby George12,Peter Van Veldhuizen13,Joshua Zhang14,Huanyu Zhao14,Nicholas Vogelzang15,John Wagstaff16
1Virginia Cancer Institute,2Tulsa Cancer Institute,3Weill Cornell Medical College,4Sarah Cannon Research Institute / Tennessee Oncology, PLLC,5University of Washington and Fred Hutchinson Cancer Research Center,6The West Clinic,7Moffitt Cancer Center,8Florida Cancer Specialists – South,9Cancer Care Centers of South Texas,10The Center for Cancer and Blood Disorders,11Fort Wayne Medical Oncology and Hematology,12Roswell Park Institute,13HCA Midwest Division,14Bristol-Myers Squibb,15Comprehensive Cancer Centers of Nevada,16Swansea University

Unravelling the role of novel uncharacterised long non-coding RNAs in the control of cell fate

Year:

Session type:

Theme:

Katerina Bountali1,Mirna Mourtada-Maarabouni1
1Keele University

New model for estimating glomerular filtration rate in patients with cancer results improves accuracy of carboplatin chemotherapy dosing

Year:

Session type:

Theme:

Edward Williams1,Tobias Janowiz1,Andrea Marshall2,Nicola Ainsworth3,Peter Thomas4,Stephen Sammut1,Scott Shepherd5,Jeff White5,Patrick Mark5,Andy Lynch1,Duncan Joderell1,Simon Tavaré1,Helena Earl6
1Cancer Research UK Cambridge Institute,2Warwick Medical School,3Queen Elizabeth Hospital, King's Lynn,4University of Cambridge,5Beatson West of Scotland Cancer Centre,6Department of Oncology, University of Cambridge

Ultrasound-responsive lactic acid based agents for the delivery of targeted radiotherapy to solid tumours

Year:

Session type:

Theme:

Irini Skaripa-Koukelli1,Ole Tietz1,Christophoros Mannaris2,Jason Brown3,Joshua Owen2,Robert Carlisle2,Katherine Vallis1
1CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology,2Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford,3Department of Physics, University of Oxford

Evaluation of single cell co-expression profiles of immune checkpoint therapeutic targets in the tumor microenvironment of Non-small Cell Lung Cancer

Year:

Session type:

Theme:

Bradley Spencer-Dene1,Faraia Shah1,Na Li1,Jeff Kim1,Xiao-Jun Ma1,Emily Park1
1Advanced Cell Diagnostics

c-MYC – a novel regulator of mitotic cell fate which influences paclitaxel chemosensitivity in epithelial ovarian cancer?

Year:

Session type:

Theme:

Sarah Hawco1,Lindsey Allan1,Aparajitha Vaidyanathan1,Michelle Ferguson2,Russell Petty1,Gillian Smith1,Paul Clarke1
1University of Dundee,2NHS Tayside

Page 1 of 781...25...Last »